Psychedelic Medicine at the End of Life

Auteur

Dr. Richard Louis Miller, MA, PhD, has been a clinical psychologist for more than 50 years. He is host of the syndicated talk radio show, Mind Body Health & Politics. The founder of the nationally acclaimed Cokenders Alcohol and Drug Program, he has been a faculty member at the University of Michigan and Stanford University, an advisor on the President’s Commission on Mental Health, a founding board member of the Gestalt Institute of San Francisco, and a member of the national board of directors for the Marijuana Policy Project. He lives in Fort Bragg and Wilbur Hot Springs, California.

Texte du rabat

A cutting-edge exploration of the role of psychedelics in the end-of-life experience

Résumé
A cutting-edge exploration of the role of psychedelics in the end-of-life experience

Contenu

FOREWORD BY RICK DOBLIN, Ph.D.

PROLOGUE

PART ONE

THE CASE FOR PSYCHEDELICS
AT THE END OF LIFE

CHAPTER 1
Ego Death

CHAPTER 2
**From Taboo to Trials: Pioneers of the Psychedelic
Renaissance

CHAPTER 3
Studies of Psychedelics for End-of-Life Distress:
Proof of Safety and Efficacy

CHAPTER 4
Mechanism of Action: How Psychedelics Help the Dying
Overcome End-of-Life Distress

CHAPTER 5
Understanding and Treating End-of-Life Distress

**PART TWO

**THE STEPS TO DYING GRACEFULLY

STEP 1
Confronting Death

STEP 2
**Discerning Candidacy for
Psychedelic-Assisted Psychotherapy

STEP 3
Navigating the Legal Landscape

STEP 4
Selecting the Guide, Dose, and Therapy Type

STEP 5
Managing Set and Setting

STEP 6
Surrendering

STEP 7
Integrating the Insights

STEP 8
**Reckoning with the Afterlife

STEP 9
Living Fully

STEP 10
Dying Gracefully

Reconnecting in an Age of Separation

EPILOGUE
The Way Forward

AFTERWORD

REFERENCES

INDEX